VentriPoint Diagnostics Ltd V.VPT

RE:RE:RE:RE:RE:New Press Release - Ventripoint Receives Medical Device License from Health Canada to Sell Next Generation, AI-powered, Heart-scanning Technology

[jopatclo]

GranhamB see same mec on CEO see...is  Walk See is V4.0 Post on Linkedin Bart Hendriks 3 months ago Post-Event Highlights from AEPC 2024 in Porto! Ventripoint Diagnostics Ltd. Shines as the Star of the Show What an exhilarating experience at AEPC 2024! We are immensely proud to have showcased our advanced AI-powered heart-scanning software, VMS+4.0, which became the talk of the conference. Thank you to everyone who joined us in Porto for your enthusiasm and engaging discussions. Key Takeaways from AEPC 2024: VMS Strain and Heat Maps: Our demonstrations highlighted how VMS+4.0’s visualization tools, especially the strain and heat maps, provide unparalleled insights into heart function. Cardiologists from around the globe were impressed by the precision and detail our software brings to cardiac diagnostics. Automated Plotting of Key Anatomical Landmarks: Attendees experienced firsthand how VMS+4.0 simplifies and enhances cardiac assessments. The elimination of manual plotting not only streamlines the diagnostic process but also increases accuracy and reliability in volumetric measurements. The feedback has been overwhelmingly positive, reinforcing our belief that VMS+4.0 will revolutionize cardiac care by making advanced diagnostics quicker and more accessible. Moving Forward: As we continue to await FDA approval, our resolve to deliver VMS+4.0 to healthcare providers worldwide has only strengthened. The interest and inquiries from international cardiologists and healthcare institutions at AEPC have been inspiring. Ventripoint: The New Standard in Cardiac Imaging With VMS+4.0, we're not just following trends – we're setting them. Our technology stood out as a beacon of innovation and practicality, proving that we are at the forefront of medical technology. Thank you again for making us the star of AEPC 2024! We look forward to bringing our cutting-edge solutions to your hospitals and clinics. hashtag#Ventripoint hashtag#HeartHealth hashtag#MedicalInnovation hashtag#AI hashtag#FDA hashtag#Cardiology hashtag#AEPC2024 hashtag#PostAEPC Special thanks to the Ventripoint Diagnostics Ltd. team, the Angiopro GmbH team GmbH, the CardioLogic Ltd team, the President of the AEPC, Dr. Nico Blom, Dr. Kai Thorsten Laser, and the participants of the VMS+ workshop, Tineke Willems and so many others for their interest and time at our booth. For ongoing updates or to get in touch, continue to follow our journey!

jopatclo wrote: For you Pandora who loves every good news come post your FUD venom.Thanks to the negatives for diluting this news as usual today, I am a buyer Impressive The FUD team is working hard all at the same time! Like this week at the Mayo Clinic @cardinal their biggest of the big. What building is that Now that V4.0 is ok for Canada, exciting time .Solutions to cardiac clinicians worldwide. Ventripoint Diagnostics Ltd. has received a medical device license from Health Canada for its latest product offering, VMS+4.0. This is a major milestone for Ventripoint as it continues to innovate and provide cutting-edge solutions to cardiac clinicians worldwide. FDA V4.0 and Sales at any time now Insiders know!